Of mice and men: Neuropeptide Y and its receptors are associated with atherosclerotic lesion burden and vulnerability

Journal of Cardiovascular Translational Research

Volumn 4, Issue 3, 2011, Pages 351-362

  Li, Lijun ^a   Najafi, Amir H ^c   Kitlinska, Joanna B ^a   Neville, Richard ^b   Laredo, James ^b   Epstein, Stephen E ^c   Burnett, Mary Susan ^c   Zukowska, Zofia ^d  

^a GEORGETOWN UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MEDSTAR RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

DPPIV; Human; Murine atherosclerosis; Neovascularization; Neuropeptide Y; NPY receptors; Platelets

Indexed keywords

ANDROGEN; CD31 ANTIGEN; DIPEPTIDYL PEPTIDASE IV; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y5 RECEPTOR;

ADULT; ADVENTITIA; AGED; ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE PREDISPOSITION; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; MACROPHAGE; MALE; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; SEX DIFFERENCE; SMOOTH MUSCLE FIBER; THROMBOCYTE; UPREGULATION;

ADULT; AGED; ANALYSIS OF VARIANCE; ANIMALS; ANTIGENS, CD31; APOLIPOPROTEINS E; ARTERIES; ATHEROSCLEROSIS; BLOOD PLATELETS; CASE-CONTROL STUDIES; DIPEPTIDYL PEPTIDASE 4; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LINEAR MODELS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; NEUROPEPTIDE Y; PERIPHERAL ARTERIAL DISEASE; POLYMERASE CHAIN REACTION; RECEPTORS, NEUROPEPTIDE Y; SEVERITY OF ILLNESS INDEX; SEX FACTORS; UP-REGULATION; YOUNG ADULT;

ANIMALIA; MURINAE; MUS; RATTUS;

EID: 79960554469     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-011-9271-5     Document Type: Article

References (47)

1. Zukowska-Grojec, Z., Karwatowska-Prokopczuk, E., Rose, W., Rone, J., Movafagh, S., Ji, H., et al. (1998). Neuropeptide Y: A novel angiogenic factor from the sympathetic nerves and endothelium. Circulation Research, 83(2), 187-195. (Pubitemid 28354463)
2. Wheway, J., Mackay, C. R., Newton, R. A., Sainsbury, A., Boey, D., Herzog, H., et al. (2005). A fundamental bimodal role for neuropeptide Y1 receptor in the immune system. The Journal of Experimental Medicine, 202(11), 1527-1538. (Pubitemid 41746599)
3. Myers, A. K., Farhat, M. Y., Vaz, C. A., Keiser, H. R., & Zukowska-Grojec, Z. (1988). Release of immunoreactiveneuropeptide by rat platelets. Biochemical and Biophysical Research Communications, 155(1), 118-122.
4. Myers, A. K., Abi-Younes, S., & Zukowska-Grojec, Z. (1991). Re-evaluation of the effects of neuropeptide Y on aggregation of human platelets. Life Sciences, 49(7), 545-551.
5. Ericsson, A., Schalling, M., McIntyre, K. R., Lundberg, J. M., Larhammar, D., Seroogy, K., et al. (1987). Detection of neuropeptide Y and its mRNA in megakaryocytes: Enhanced levels in certain autoimmune mice. Proceedings of the National Academy of Sciences of the United States of America, 84(16), 5585-5589.
6. Dutton, M. A., Lee, E. W., & Zukowska, Z. (2006). NPY and extreme stress: Lessons learned from posttraumatic stress disorder. EXS, 95, 213-222.
7. Zukowska-Grojec, Z. (1995). Neuropeptide Y. A novel sympathetic stress hormone and more. Annals of the New York Academy of Sciences, 771, 219-233. (Pubitemid 26077409)
8. Heilig, M. (2004). The NPY system in stress, anxiety and depression. Neuropeptides, 38(4), 213-224. (Pubitemid 39158860)
9. Zukowska, Z. (2005). Atherosclerosis and angiogenesis: What do nerves have to do with it? Pharmacological Reports, 57(Suppl), 229-234.
10. Blomqvist, A. G., & Herzog, H. (1997). Y-receptor subtypes - How many more? Trends in Neurosciences, 20(7), 294-298. (Pubitemid 27348738)
11. Kalra, S. P., Dube, M. G., Sahu, A., Phelps, C. P., & Kalra, P. S. (1991). Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food. Proceedings of the National Academy of Sciences of the United States of America, 88(23), 10931-10935. (Pubitemid 21915953)
12. Heilig, M., Soderpalm, B., Engel, J. A., & Widerlov, E. (1989). Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models. Psychopharmacology (Berl), 98(4), 524-529. (Pubitemid 19193902)
13. Heilig, M. (1995). Antisense inhibition of neuropeptide Y (NPY) - Y1 receptor expression blocks the anxiolytic-like action of NPY in amygdala and paradoxically increases feeding. Regulatory Peptides, 59(2), 201-205.
14. Heilig, M., Wahlestedt, C., Ekman, R., & Widerlov, E. (1988). Antidepressant drugs increase the concentration of neuropeptide Y (NPY)-like immunoreactivity in the rat brain. European Journal of Pharmacology, 147(3), 465-467. (Pubitemid 18076508)
15. Holmes, A., Heilig, M., Rupniak, N. M., Steckler, T., & Griebel, G. (2003). Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders. Trends in Pharmacological Sciences, 24(11), 580-588. (Pubitemid 37357142)
16. Zukowska-Grojec, Z., Dayao, E. K., Karwatowska-Prokopczuk, E., Hauser, G. J., & Doods, H. N. (1996). Stress-induced mesenteric vasoconstriction in rats is mediated by neuropeptide Y Y1 receptors. The American Journal of Physiology, 270(2 Pt 2), H796-H800.
17. Zukowska-Grojec, Z., Pruszczyk, P., Colton, C., Yao, J., Shen, G. H., Myers, A. K., et al. (1993). Mitogenic effect of neuropeptide Y in rat vascular smooth muscle cells. Peptides, 14(2), 263-268.
18. Pons, J., Kitlinska, J., Ji, H., Lee, E. W., & Zukowska, Z. (2003). Mitogenic actions of neuropeptide Y in vascular smooth muscle cells: Synergetic interactions with the beta-adrenergic system. Canadian Journal of Physiology and Pharmacology, 81(2), 177-185. (Pubitemid 36398892)
19. Zukowska, Z., Grant, D. S., & Lee, E. W. (2003). Neuropeptide Y: A novel mechanism for ischemic angiogenesis. Trends in Cardiovascular Medicine, 13(2), 86-92. (Pubitemid 36173862)
20. Ekstrand, A. J., Cao, R., Bjorndahl, M., Nystrom, S., Jonsson-Rylander, A. C., Hassani, H., et al. (2003). Deletion of neuropeptide Y (NPY) 2 receptor in mice results in blockage of NPY-induced angiogenesis and delayed wound healing. Proceedings of the National Academy of Sciences of the United States of America, 100(10), 6033-6038. (Pubitemid 36576926)
21. Koulu, M., Movafagh, S., Tuohimaa, J., Jaakkola, U., Kallio, J., Pesonen, U., et al. (2004). Neuropeptide Y and Y2-receptor are involved in development of diabetic retinopathy and retinal neovascularization. Annals of Medicine, 36(3), 232-240. (Pubitemid 38680200)
22. Kitlinska, J., Abe, K., Kuo, L., Pons, J., Yu, M., Li, L., et al. (2005). Differential effects of neuropeptide Y on the growth and vascularization of neural crest-derived tumors. Cancer Research, 65(5), 1719-1728. (Pubitemid 40478597)
23. Marsh, D. J., Hollopeter, G., Kafer, K. E., & Palmiter, R. D. (1998). Role of the Y5 neuropeptide Y receptor in feeding and obesity. Nature Medicine, 4(6), 718-721. (Pubitemid 28274674)
24. Lee, E. W., Grant, D. S., Movafagh, S., & Zukowska, Z. (2003). Impaired angiogenesis in neuropeptide Y (NPY)-Y2 receptor knockout mice. Peptides, 24(1), 99-106. (Pubitemid 36165180)
25. Li, L., Lee, E. W., Ji, H., & Zukowska, Z. (2003). Neuropeptide Y-induced acceleration of postangioplasty occlusion of rat carotid artery. Arteriosclerosis, Thrombosis, and Vascular Biology, 23(7), 1204-1210. (Pubitemid 36871274)
26. Li, L., Jonsson-Rylander, A. C., Abe, K., & Zukowska, Z. (2005). Chronic stress induces rapid occlusion of angioplasty-injured rat carotid artery by activating neuropeptide Y and its Y1 receptors. Arteriosclerosis, Thrombosis, and Vascular Biology, 25(10), 2075-2080. (Pubitemid 41416303)
27. Zoccali, C., Mallamaci, F., Tripepi, G., Benedetto, F. A., Parlongo, S., Cutrupi, S., et al. (2003). Prospective study of neuropeptide y as an adverse cardiovascular risk factor in end-stage renal disease. Journal of the American Society of Nephrology, 14(10), 2611-2617. (Pubitemid 37169347)
28. Maisel, A. S., Scott, N. A., Motulsky, H. J., Michel, M. C., Boublik, J. H., Rivier, J. E., et al. (1989). Elevation of plasma neuropeptide Y levels in congestive heart failure. The American Journal of Medicine, 86(1), 43-48. (Pubitemid 19039536)
29. Kallio, J., Pesonen, U., Kaipio, K., Karvonen, M. K., Jaakkola, U., Heinonen, O. J., et al. (2001). Altered intracellular processing and release of neuropeptide Y due to leucine 7 to proline 7 polymorphism in the signal peptide of preproneuropeptide Y in humans. The FASEB Journal, 15(7), 1242-1244.
30. Karvonen, M. K., Pesonen, U., Koulu, M., Niskanen, L., Laakso, M., Rissanen, A., et al. (1998). Association of a leucine (7)-toproline (7) polymorphism in the signal peptide of neuropeptide Y with high serum cholesterol and LDL cholesterol levels. Nature Medicine, 4(12), 1434-1437. (Pubitemid 28553469)
31. Pesonen, U. (2008). NPY L7P polymorphism and metabolic diseases. Regulatory Peptides, 149(1-3), 51-55.
32. Shah, S. H., Freedman, N. J., Zhang, L., Crosslin, D. R., Stone, D. H., Haynes, C., et al. (2009). Neuropeptide Y gene polymorphisms confer risk of early-onset atherosclerosis. PLoS Genetics, 5(1), e1000318.
33. Piedrahita, J. A., Zhang, S. H., Hagaman, J. R., Oliver, P. M., & Maeda, N. (1992). Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America, 89(10), 4471-4475.
34. Breslow, J. L. (1996). Mouse models of atherosclerosis. Science, 272(5262), 685-688. (Pubitemid 26000273)
35. Schwartz, S., Galis, Z., Rosenfeld, M., & Falk, E. (2007). Plaque rupture in humans and mice. Arteriosclerosis, Thrombosis, and Vascular Biology, 27, 705-713. (Pubitemid 46606695)
36. Falk, E., Schwartz, S., Galis, Z., & Rosenfeld, M. (2007). Putative murine models of plaque rupture. Arteriosclerosis, Thrombosis, and Vascular Biology, 27, 969-972. (Pubitemid 46606733)
37. Kolodgie, F. D., Burke, A. P., Nakazawa, G., Cheng, Q., Xu, X., & Virmani, R. (2007). Free cholesterol in atherosclerotic plaques: Where does it come from? Current Opinion in Lipidology, 18(5), 500-507. (Pubitemid 47462201)
38. Kolodgie, F. D., Gold, H. K., Burke, A. P., Fowler, D. R., Kruth, H. S., Weber, D. K., et al. (2003). Intraplaque hemorrhage and progression of coronary atheroma. The New England Journal of Medicine, 349(24), 2316-2325. (Pubitemid 37509739)
39. Virmani, R., Kolodgie, F. D., Burke, A. P., Finn, A. V., Gold, H. K., Tulenko, T. N., et al. (2005). Atherosclerotic plaque progression and vulnerability to rupture: Angiogenesis as a source of intraplaque hemorrhage. Arteriosclerosis, Thrombosis, and Vascular Biology, 25(10), 2054-2061. (Pubitemid 41416300)
40. Ghersi, G., Chen, W., Lee, E. W., & Zukowska, Z. (2001). Critical role of dipeptidyl peptidase IV in neuropeptide Y-mediated endothelial cell migration in response to wounding. Peptides, 22(3), 453-458. (Pubitemid 32250247)
41. Lee, E. W., Michalkiewicz, M., Kitlinska, J., Kalezic, I., Switalska, H., Yoo, P., et al. (2003). Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles. Journal of Clinical Investigation, 111(12), 1853-1862. (Pubitemid 38057730)
42. Oravecz, T., Pall, M., Roderiquez, G., Gorrell, M. D., Ditto, M., Nguyen, N. Y., et al. (1997). Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage. The Journal of Experimental Medicine, 186(11), 1865-1872. (Pubitemid 27524596)
43. Shioda, T., Kato, H., Ohnishi, Y., Tashiro, K., Ikegawa, M., Nakayama, E. E., et al. (1998). Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1alpha (SDF-1alpha) and SDF-1beta are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage. Proceedings of the National Academy of Sciences of the United States of America, 95(11), 6331-6336. (Pubitemid 28249012)
44. Mentlein, R. (1999). Dipeptidyl-peptidase IV (CD26)-Role in the inactivation of regulatory peptides. Regulatory Peptides, 85(1), 9-24. (Pubitemid 29505281)
45. Zukowska-Grojec, Z., Shen, G. H., Capraro, P. A., & Vaz, C. A. (1991). Cardiovascular, neuropeptide Y, and adrenergic responses in stress are sexually differentiated. Physiology & Behavior, 49(4), 771-777.
46. Urban, J. H., Bauer-Dantoin, A. C., & Levine, J. E. (1993). Neuropeptide Y gene expression in the arcuate nucleus: Sexual dimorphism and modulation by testosterone. Endocrinology, 132(1), 139-145. (Pubitemid 23019494)
47. Campbell, C. D., Lyon, H. N., Nemesh, J., Drake, J. A., Tuomi, T., Gaudet, D., et al. (2007). Association studies of BMI and type 2 diabetes in the neuropeptide Y pathway: A possible role for NPY2R as a candidate gene for type 2 diabetes in men. Diabetes, 56(5), 1460-1467. Epub 2007 Feb. 26. (Pubitemid 46715623)